Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP54036.RA9_jhZlEBIyf5Yzr54HtiVT2tLbH-zkQZ1l_HluhVBGI130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP54036.RA9_jhZlEBIyf5Yzr54HtiVT2tLbH-zkQZ1l_HluhVBGI130_provenance.
• NP76539.RA1pxLfhFCNUMja4slvd0vPc1ujMCoYgQFL4RlLu2-XGI130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP76539.RA1pxLfhFCNUMja4slvd0vPc1ujMCoYgQFL4RlLu2-XGI130_provenance.
• assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP112076.RAbzVZ1Vq9rX4W7Bp9v7KEUF1HTONUOSw1Io--tDalZQ8130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112076.RAbzVZ1Vq9rX4W7Bp9v7KEUF1HTONUOSw1Io--tDalZQ8130_provenance.
• NP340678.RAXfhnYkKSXkjejd0XXflgYC2zREg20Rc0lUrYvVhftFY130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340678.RAXfhnYkKSXkjejd0XXflgYC2zREg20Rc0lUrYvVhftFY130_provenance.
• NP50473.RAtUxHA2infml_h1sa0DgmBjs3fPTCRA2VrRX4p4B6p8M130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50473.RAtUxHA2infml_h1sa0DgmBjs3fPTCRA2VrRX4p4B6p8M130_provenance.
• NP143514.RAQ_bBRGFCwy85OWkNFgPTOICGTE3fAppUJ4N6igbjHhQ130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP143514.RAQ_bBRGFCwy85OWkNFgPTOICGTE3fAppUJ4N6igbjHhQ130_provenance.
• NP143515.RAbi4ae88dm59cDIxbHwlmTZxe4dcelPkFWEx36wNrpLE130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP143515.RAbi4ae88dm59cDIxbHwlmTZxe4dcelPkFWEx36wNrpLE130_provenance.
• NP143516.RAZFzTNld_dVZT6CPcw81J0sjsQtrF8epQcMimGcq8jAg130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP143516.RAZFzTNld_dVZT6CPcw81J0sjsQtrF8epQcMimGcq8jAg130_provenance.
• NP727451.RAZ57_hKnU6uRfemrQRIXPp1B4XtsyPRod7wP375U3FAU130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP727451.RAZ57_hKnU6uRfemrQRIXPp1B4XtsyPRod7wP375U3FAU130_provenance.
• NP50990.RAxFkV8jFuyZ-JZAChEEaf5tQQOoaByjO9EQyRB1ttk8g130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50990.RAxFkV8jFuyZ-JZAChEEaf5tQQOoaByjO9EQyRB1ttk8g130_provenance.
• NP340564.RAoo8j16B1GGtBwK1in9gAGpFyQw3-mwwKP5Q1ikqodAQ130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340564.RAoo8j16B1GGtBwK1in9gAGpFyQw3-mwwKP5Q1ikqodAQ130_provenance.
• NP727445.RArRkLi0kJHSKTVFBWrgk70klGXfcgSCWswiFWwvXeX9c130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP727445.RArRkLi0kJHSKTVFBWrgk70klGXfcgSCWswiFWwvXeX9c130_provenance.
• NP727450.RAt7gGQSXaKV_-H7pX39Dw_oNTAy3LNzOolp0NGo4nDp4130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP727450.RAt7gGQSXaKV_-H7pX39Dw_oNTAy3LNzOolp0NGo4nDp4130_provenance.
• NP67761.RAJkuVKzTd9FM5POdQ2C7PK2PVeyaXzyRJWuKX9UXwclo130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP67761.RAJkuVKzTd9FM5POdQ2C7PK2PVeyaXzyRJWuKX9UXwclo130_provenance.
• NP340731.RA4_RHtYxQmKZTu0_HmyT_jNPmO6g6GgveKJ7k_QcZgXw130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340731.RA4_RHtYxQmKZTu0_HmyT_jNPmO6g6GgveKJ7k_QcZgXw130_provenance.
• NP340763.RA3zTHCSLAmYw0wolFA8gJnDGM7fnREkDufrmqkaF72k4130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340763.RA3zTHCSLAmYw0wolFA8gJnDGM7fnREkDufrmqkaF72k4130_provenance.
• NP112067.RAEfxvxtzxl5-DzoZhmplgHkUZFIjsICoZjAy3RAPPomo130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112067.RAEfxvxtzxl5-DzoZhmplgHkUZFIjsICoZjAy3RAPPomo130_provenance.
• NP143513.RAMUkKLIl0dJeTzNJbTt5fl_0SqC_cg8Bi2CTz9L8hVt0130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP143513.RAMUkKLIl0dJeTzNJbTt5fl_0SqC_cg8Bi2CTz9L8hVt0130_provenance.
• NP727453.RAPTPRIHFBbBNIA7pg3TX3JB2OV2qnXxN88rEbB1fT7D4130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP727453.RAPTPRIHFBbBNIA7pg3TX3JB2OV2qnXxN88rEbB1fT7D4130_provenance.
• NP143512.RA1j84-cVhal8nZuBrptBPih4vImmKb0Q8om3IPjog13A130_assertion description "[Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP143512.RA1j84-cVhal8nZuBrptBPih4vImmKb0Q8om3IPjog13A130_provenance.